By rray, 12 July, 2024 Exclude Patient Type Detail Header No Detail Type Text Detail Text May offer to pts unable unwilling to undergo behavioral noninvasive or pharmacological therapies CP nbsp nbsp If inadequate response to behavioral tx or medication mgmt PTNS implantable tibial nerve stimulation BTX and SNM assoc w high success rates durab Offer in the context of shared decision making trials of behavioral noninvasive or pharmacological mgmt not required EO Discontinue oral meds if appropriate response to minimally invasive procedure but restart if efficacy not maintained EO nbsp nbsp If good tx response There s likely no added benefit to continuing OAB meds are assoc w polypharmacy added cost and potential Patient Type Detail Header (Long) Minimally invasive therapies